---
title: "Carecloud Pref Share CCLDO 8.75 Prep 02/15/24 B | 10-Q: FY2025 Q3 Revenue: USD 31.07 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/264738551.md"
datetime: "2025-11-06T22:55:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/264738551.md)
  - [en](https://longbridge.com/en/news/264738551.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/264738551.md)
generator: "portal-rs"
---

# Carecloud Pref Share CCLDO 8.75 Prep 02/15/24 B | 10-Q: FY2025 Q3 Revenue: USD 31.07 M

Revenue: As of FY2025 Q3, the actual value is USD 31.07 M.

EPS: As of FY2025 Q3, the actual value is USD 0.04.

EBIT: As of FY2025 Q3, the actual value is USD 3.262 M.

### Healthcare IT Segment

#### Net Revenue

-   $75.6 million for the nine months ended September 30, 2025
-   $26.8 million for the three months ended September 30, 2025

#### Operating Expenses

-   Direct Operating Costs: $37.9 million for the nine months ended September 30, 2025
-   Selling and Marketing: $3.4 million for the nine months ended September 30, 2025
-   General and Administrative: $7.4 million for the nine months ended September 30, 2025
-   Research and Development: $3.8 million for the nine months ended September 30, 2025
-   Depreciation and Amortization: $10.5 million for the nine months ended September 30, 2025
-   Restructuring Costs: $154,000 for the nine months ended September 30, 2025

#### Operating Income

-   $12.4 million for the nine months ended September 30, 2025
-   $4.2 million for the three months ended September 30, 2025

### Medical Practice Management Segment

#### Net Revenue

-   $10.5 million for the nine months ended September 30, 2025
-   $4.2 million for the three months ended September 30, 2025

#### Operating Expenses

-   Direct Operating Costs: $8.3 million for the nine months ended September 30, 2025
-   Selling and Marketing: $22,000 for the nine months ended September 30, 2025
-   General and Administrative: $1.9 million for the nine months ended September 30, 2025
-   Depreciation and Amortization: $246,000 for the nine months ended September 30, 2025

#### Operating Income

-   $123,000 for the nine months ended September 30, 2025
-   $502,000 for the three months ended September 30, 2025

### Consolidated Metrics

#### Total Net Revenue

-   $86.1 million for the nine months ended September 30, 2025
-   $31.1 million for the three months ended September 30, 2025

#### Total Operating Expenses

-   $77.9 million for the nine months ended September 30, 2025
-   $27.9 million for the three months ended September 30, 2025

#### Operating Income

-   $8.2 million for the nine months ended September 30, 2025
-   $3.2 million for the three months ended September 30, 2025

#### Net Income

-   $7.9 million for the nine months ended September 30, 2025
-   $3.1 million for the three months ended September 30, 2025

### Cash Flow

#### Operating Cash Flow

-   $19.9 million for the nine months ended September 30, 2025

#### Free Cash Flow

-   Net cash used in investing activities: - $21.2 million for the nine months ended September 30, 2025

### Future Outlook and Strategy

#### Core Business Focus

-   The company plans to continue enhancing its liquidity and financial position by managing expenses and growing revenue. Management expects these efforts to improve profitability and overall financial health.

#### Non-Core Business

-   The company acquired MAP App, a hospital benchmarking tool, and created a new subsidiary, N884AM Holdings, Inc., for purchasing an aircraft to visit current and prospective clients.

### Related Stocks

- [CCLDO.US](https://longbridge.com/en/quote/CCLDO.US.md)

## Related News & Research

- [3,759 Shares in Ferrari N.V. $RACE Acquired by X Square Capital LLC](https://longbridge.com/en/news/296700358.md)
- [Powerful Growth, Multiple Endorsements Bode Well for Oracle Stock](https://longbridge.com/en/news/296686709.md)
- [Korea Investment CORP Increases Stock Position in L3Harris Technologies Inc $LHX](https://longbridge.com/en/news/296698330.md)
- [Johnson & Johnson $JNJ Position Reduced by Oppenheimer Asset Management Inc.](https://longbridge.com/en/news/296697035.md)
- [Danske Bank A S Invests $252.05 Million in Bank of America Corporation $BAC](https://longbridge.com/en/news/296695181.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**